,
,
,
,
,
,
,
,
,
,
,
,
Management of hypertension in the elderly patient at abidjan cardiology institute (ivory coast), Int J Hypertens, p.651634, 2012. ,
Management of elderly hypertension: Whom to trat and how low to go, J Hypertens, vol.34, issue.1, p.182, 2016. ,
Polypharmacy in the Aging Patient: Management of Hypertension in Octogenarians, JAMA, vol.314, issue.2, pp.170-80, 2015. ,
Immediate and late benefits of treating very elderly people with hypertension: results from active treatment extension to Hypertension in the Very Elderly randomised controlled trial, BMJ, vol.344, p.7541, 2011. ,
URL : https://hal.archives-ouvertes.fr/hal-01335743
An Expert Opinion From the European Society of Hypertension-European Union Geriatric Medicine Society Working Group on the Management of Hypertension in Very Old, Frail Subjects, vol.67, pp.820-825, 1979. ,
The "iatrogenic triad": polypharmacy, drug-drug interactions, and potentially inappropriate medications in older adults, Int J Clin Pharm, 2017. ,
The risk of hip fracture after initiating antihypertensive drugs in the elderly, Arch Intern Med, 2012. ,
Impact of Hospitalization on Antihypertensive Pharmacotherapy among Older Persons. Drugs-real world outcomes, vol.2, pp.239-286, 2015. ,
maladies cardio-neuro-vasculaires: L'hypertension artérielle, 2017. ,
Recommandation prise en charge de l'hypertension artérielle. Société Française de l'hypertension artérielle ,
New NICE guidelines for hypertension, BMJ, vol.343, p.5644, 2011. ,
, , 2013.
Guidelines for the management of arterial hypertension: the Task Force for the management of arterial hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC), J Hypertens, 2013. ,
A practical approach to the pharmacological management of hypertension in older people, Ther Adv drug Saf, vol.8, issue.4, pp.117-149, 2017. ,
Burden of frailty in the elderly population: perspectives for a public health challenge, Arch public Health, vol.73, issue.1, p.19, 2015. ,
Frailty Syndrome: A Review, J Assoc Physicians India, vol.62, issue.11, pp.34-42, 2014. ,
Polypharmacy Is Associated With Higher Frailty Risk in Older People: An 8-Year Longitudinal Cohort Study, J Am Med Dir Assoc, 2017. ,
Is Polypharmacy Associated with Frailty in Older People? Results From the ESTHER Cohort Study, J Am Geriatr Soc, vol.65, issue.2, pp.27-32, 2017. ,
Frailty and polypharmacy in elderly patients are associated with a high readmission risk, Dan Med J, vol.63, issue.9, 2016. ,
Blood pressure and 10-year mortality risk in the Milan Geriatrics 75+ Cohort Study: role of functional and cognitive status, Age Ageing, vol.44, issue.6, pp.932-939, 2015. ,
Medication prescribing in frail older people, Eur J Clin Pharmacol, vol.69, issue.3, pp.319-345, 2013. ,
Combination therapy of hypertension in the elderly: a subgroup analysis of the Combination of OLMesartan and a calcium channel blocker or diuretic in Japanese elderly hypertensive patients trial, Hypertens Res, vol.38, issue.1, pp.89-96, 2015. ,
Treatment With Multiple Blood Pressure Medications, Achieved Blood Pressure, and Mortality in Older Nursing Home Residents: The PARTAGE Study, JAMA Intern Med, vol.175, issue.6, pp.989-95, 2015. ,
Relationship between polypharmacy and underprescribing, Br J Clin Pharmacol, vol.65, issue.1, pp.130-133, 2008. ,
Multiprofessional Treatment of High Blood Pressure in Very Elderly Patients. Arq Bras Cardiol, vol.108, pp.53-62, 2017. ,
, Comment améliorer la qualité et la sécurité des prescriptions de médicaments chez la personne âgée ?, HAS, 2014.
,
, Cad Saude Publica, vol.30, issue.9, pp.1947-56, 2014.
Challenges in the Management of Hypertension in Older Populations, Adv Exp Med Biol, vol.956, pp.167-180, 2017. ,
Managing hypertension in the very elderly: effect of adverse drug reactions (ADRs) on achieving targets, J Hum Hypertens, vol.24, issue.8, pp.514-522, 2010. ,
Management of Hypertension in the Elderly and Frail Elderly, vol.24, pp.1-11, 2017. ,
Lower dementia risk with different classes of antihypertensive medication in older patients, J Hypertens, 2017. ,
Beta-blockers for hypertension. Cochrane database Syst Rev, vol.1, p.2003, 2017. ,
Reexamining the Effect of Antihypertensive Medications on Falls in Old Age, Hypertens, vol.66, issue.1, pp.183-192, 1979. ,
URL : https://hal.archives-ouvertes.fr/hal-01152362
No evidence that frailty modifies the positive impact of antihypertensive treatment in very elderly people: an investigation of the impact of frailty upon treatment effect in the HYpertension in the Very Elderly Trial (HYVET) study, a double-blind, placeb, BMC Med, vol.13, p.78, 2015. ,
Treatment of high blood pressure in elderly and octogenarians: European Society of Hypertension statement on blood pressure targets, vol.25, pp.333-339, 2016. ,
Antihypertensive Medications, Loop Diuretics, and Risk of Hip Fracture in the Elderly: A Population-Based Cohort Study of 81,617 Italian Patients Newly Treated Between, Drugs Aging, vol.32, issue.11, pp.927-963, 2005. ,
Resistant hypertension in the elderly-second line treatments: aldosterone antagonists, central alpha-agonist agents, alpha-adrenergic receptor blockers, direct vasodilators, and exogenous nitric oxide donors, Cardiovasc Hematol Agents Med Chem, vol.12, issue.3, pp.170-173, 2015. ,
Comprehensive geriatric assessment for older adults admitted to hospital: meta-analysis of randomised controlled trials, BMJ, vol.343, p.6553, 2011. ,
Impact of hospitalization in an acute geriatric unit on polypharmacy and potentially inappropriate prescriptions: A retrospective study, Geriatr Gerontol Int, 2017. ,